Gynaecology Drug Handbook AK Debdas
INDEX
×
Chapter Notes

Save Clear


1Medical Treatment of Menstrual Disorders
• Medical Treatment of Some ‘Specific’ Causes of Secondary Amenorrhoea.
  • Post ‘Pill’ Amenorrhoea
  • Lactational Amenorrhoea
  • Amenorrhoea Following Depo-progestin Contraceptive Inj
  • Premature Menopause
  • Resistant Ovary Syndrome
  • Sheehan's Syndrome
• Causes of Secondary Amenorrhoea ‘Common with Primary Amenorrhoea’ and their Medical Management
• Medical Management of Non-organic Causes of Secondary Amenorrhoea
• Causes of Secondary Amenorrhoea which Cannot be Treated by Drugs
2

Drugs for Treatment of Primary AmenorrhoeaCHAPTER 1

 
DEFINITION
Past 15 years, not menstruated yet (Beiber, 2006). Bone age is a better guide than the chronological age for allocating age.
‘AT A GLANCE CHART’
For Management of Primary Amenorrhoea
I
II
III
Diagnosis (Cause)
Diagnostic Test
Drugs to be used
1. Hyperprolactinaemia with or without galactorrhoea
• Serum
prolactin-
Elevated
• CT/MRI-
To spot/exclude
Microadenoma
Bromocriptine 2.5 mg od or bd or cabergoline 0.5 mg weekly-titrated by Prolactin level
(see chapter 34 and 35).
2. Hypothyroidism
Elevated TSH
Thyroxine (Thyronorm 25, 50, 100 mcg) daily-to be titrated by TSH level
3. Hypogonadotrophic hypogonadism
Low FSH,
Low LH
Low oestrogen
(All 3 low)
Oestrogen replacement therapy for sexual development e.g. Oestrogen patch
4. Adrenal hyperplasia
Elevated plasma 17-hydroxy progesterone and DHEAS
Dexamethasone 0.5 mg -1/2 or 1 tab daily to suppress Adrenals
4
5. Peripubertal PCOD
Elevated LH and high LH/FSH ratio-more than 3: 1
1. Weight reduction
2. OC Pill Duoluton L cyclically
3. Recurrent Medroxy Progesterone withdrawal bleeding
4. Clomiphene 50-150 mg/day for 5 days-for few cycles
5. Treatment of hirsutism (see chapter 20, PCOD)
6. Cushing's syndrome
Elevated urinary free cortisol and plasma cortisol
Refer to Physician
7. Anorexia Nervosa (see chapter 32)
Weight loss, BMI <10th percentile (Beiber, 2006) under weight– > 25%, poor intake, low FSH, LH and E2 in some cases
Appetite stimulant, Anti-depressant, dietrary supplement; in severe cases admission and psychiatric consultation.
8. Exercise induced amenorrhoea
No significant abnormality.
History of heavy physical exercise-Athlete, keen dancer
Cutting down physical activity where possible
9. Pituitary microadenoma, Prolactinoma
Very high level of Prolactin, Microadenoma on CT/MRI
Bromocriptine in high doses. Refer to Neurosurgeon
10 Turner's syndrome and other forms of gonadal agenesis
High FSH and LH and very low oestrogen, Karyotype-XO, short stature
Oestrogen, Progestogen and Growth hormone (see chapter 38)
5
11 Genital Koch's
Elevated Koch's antibodies, strongly positive Mantoux, high ESR, tubercles in curetted endometrium or on pelvic organs on Laparoscopy, +ve Koch's PCR of endometrium
Anti Koch's drugs
(see Chapter 54).
* In rare case primary amenorrhoea may be caused by pregnancy and hence this also has to be excluded by urine hCG test.
* Malnutrition, under nutrition and chronic debilitating disease must be corrected.
Note: This chart applies also for ‘secondary amenorrhoea’ and ‘infrequent menstruation’.
 
THE CAUSES OF PRIMARY AMENORRHOEA THAT HAVE NO MEDICAL TREATMENT
Imperforate hymen
Needs surgery
Transverse vaginal septum
Needs surgery
Absent uterus
Not treatable
In the cases of absent uterus the following two causes are to be kept in mind.
  • Mullerian agenesis
  • Testicular feminisation-(Testes are to be removed)
Hypothalamic and pituitary tumour
Needs surgery/ Radiotherapy
Adrenal tumour
Needs surgery
6
 
Basic non-invasive investigations for primary amenorrhoea
  • Hb, TC,DC, ESR—For general health
  • US scan of pelvis—To confirm or exclude the presence of uterus and ovaries and if present their size.
  • TSH—To exclude hypothyroidism.
  • PRL— To exclude hyperprolactinaemia.
    FSH:
    Low—Hypogonadotrophism
    High—Turner's syndrome or gonadal agenesis.
 
Special Test —Karyotype
This is required only where history, clinical examination and the above investigations suggest the possibility of Turner's syndrome (XO) or Testicular feminisation (XY).
FURTHER READING
  1. Bieber EJ, Sanfilippo JS and Horowitz IR: In Clinical Gynecology, Elsevier,  2006;469-79, 818.
  1. Speroff L & Firtz MA. In Clinical Gynecologic Endocrinology and Infertility. 7th edition, Lippincott,  2005;401–63.
  1. Whitfield R. Dewhursts' Textbook of Obstetrics & Gynaecology for postgraduates, 5th edition, Blackwell Science,  Oxford,  1995;24-63 Also see under the following chapters–32, 33, 34, 35, 36, 37 and 38.